
Luce Emerson
InvestorPlace ContributorLuce Emerson is a former sell-side banker with a broad range of capital markets experience. She continues to follow markets closely, with a particular focus on retail, financials and entertainment.
Luce Emerson is a former sell-side banker with a broad range of capital markets experience. She continues to follow markets closely, with a particular focus on retail, financials and entertainment.
CGC stock still leads the space in terms of breadth of vision for CBD applications, so stick by Canopy Growth stock.
With a change in investors’ attitudes, JD stock, which is currently very undervalued, has a chance to gain some momentum.
With a number of new services including Snap Games and original premium content , it looks like the best is yet to come for SNAP stock
Twilio has been consistently making 52-week highs throughout the year, earning its spot as a leading cloud communications platform. With so much strength in the cloud computing sector amidst recent trade war-driven market swings, Twilio is a stock you want to have a position in.
Alphabet has really struggled despite running an incredibly diverse company with a huge amount of embedded option value.
For those who understand that gravity always prevails, taking a small short position in Beyond Meat stock may turn out to be an excellent trade.
After the investments from Altria, CRON stock looked like it was headed for significant growth, but Cronos stock has not delivered.
With WeWork stock, there are obstacles to its ability to grow and generate profits. People like to claim that “this time is different.” In this particular case, it just is not.
Of course, the medical opportunity is massive, but Tilray competitor, Canopy Growth (NYSE:CGC), has been aggressively pursuing a multi-pronged approach that inherently diversifies the future revenue streams. CGC’s vision for THC as an ingredient in an array of consumer products separates them from an increasingly crowded industry.
Amazon stock was a buy at the beginning of May, and it is even more of a buy now off its 52-week highs but continuing to innovate.
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.
Your Email